Search Results 681-690 of 18582 for alopecia
... alopecia) and/or complications from prior surgical intervention within 7 days before starting study treatment. Radiation therapy administered within 2 weeks ...
Any unresolved toxicity NCI CTCAE Grade ≥ 2 from previous anticancer therapy; with the exception of vitiligo and alopecia. Participating Mayo Clinic ...
... alopecia, radiation tissue fibrosis, or peripheral neuropathy) * Known allergies, hypersensitivity, or intolerance to JNJ-69086420 or its excipients and ...
Participation eligibility · Participants with vitiligo or alopecia; · Participants with hypothyroidism (eg, following Hashimoto syndrome) stable on hormone ...
... alopecia) or conditions requiring hormonal replacement therapies such as type 1 diabetes mellitus or hypothyroidism are permitted to enroll * Known ...
... alopecia, peripheral neuropathy and ongoing endocrinopathies controlled on appropriate replacement therapy * Have significant cardiovascular disease defined ...
0], with the exception of persistent alopecia, hypothyroidism, and adrenal insufficiency) due to prior treatment. NOTE: Subjects previously treated with a ...
... alopecia, or peripheral neuropathy up to grade 2 - Any major surgery =< 4 weeks prior to registration - Any serious and/or unstable pre-existing medical ...
Resolution of all acute toxic effects of prior therapy or surgical procedures to ≤Grade 1 except alopecia, stable immune-related toxicity such as ...
Significant autoimmune disease with the exception of alopecia, vitiligo, hypothyroidism or other conditions that have never been clinically active or were ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.